Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Trauner

Showing results (581-590 of 777) with videos related to

Pageof 78
Sort By:
Biomedicines|January 13, 2021
The Non-Steroidal FXR Agonist Cilofexor Improves Portal Hypertension and Reduces Hepatic Fibrosis in a Rat NASH ModelPhilipp Schwabl, Eva Hambruch, Grant R Budas, et al.
Gut|November 17, 2020
Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomesMathias Jachs, Lukas Hartl, Dunja Schaufler, et al.
Wiener Klinische Wochenschrift|December 3, 2020
Perceptions on the management of varices and on the use of albumin in patients with cirrhosis among GI specialists in AustriaNikolaus Pfisterer, Caroline Schmidbauer, Florian Riedl, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 23, 2026
The Link of Portal-Hypertensive Gastropathy to Anaemia, Systemic Inflammation and Disease Progression in CirrhosisNikolaus Pfisterer, Irina Lie-Ungurean, Jurij Maurer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 25, 2018
Outcomes after placement of a SX-ELLA oesophageal stent for refractory variceal bleeding-A national multicentre studyNikolaus Pfisterer, Florian Riedl, Thomas Pachofszky, et al.
Molecular Metabolism|April 14, 2023
Carboxylesterase 2a deletion provokes hepatic steatosis and insulin resistance in mice involving impaired diacylglycerol and lysophosphatidylcholine catabolismGabriel Chalhoub, Alina Jamnik, Laura Pajed, et al.
JHEP Reports : Innovation in Hepatology|September 30, 2022
Alpha-1 antitrypsin Pi∗Z allele is an independent risk factor for liver transplantation and death in patients with advanced chronic liver diseaseLorenz Balcar, Bernhard Scheiner, Markus Urheu, et al.
Hepatology (Baltimore, Md.)|September 3, 2014
Growth hormone resistance exacerbates cholestasis-induced murine liver fibrosisPatricia Stiedl, Robert McMahon, Leander Blaas, et al.
International Journal of Cancer|December 23, 2014
Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinomaPatrick Reichl, Meng Fang, Patrick Starlinger, et al.
Alimentary Pharmacology & Therapeutics|April 5, 2023
Disturbances in sodium and chloride homeostasis predict outcome in stable and critically ill patients with cirrhosisGeorg Semmler, Bernhard Scheiner, Lorenz Balcar, et al.
Pageof 78

Showing results (581-590 of 777) with videos related to

Sort By:
Pageof 78
Biomedicines|January 13, 2021
The Non-Steroidal FXR Agonist Cilofexor Improves Portal Hypertension and Reduces Hepatic Fibrosis in a Rat NASH ModelPhilipp Schwabl, Eva Hambruch, Grant R Budas, et al.
Gut|November 17, 2020
Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomesMathias Jachs, Lukas Hartl, Dunja Schaufler, et al.
Wiener Klinische Wochenschrift|December 3, 2020
Perceptions on the management of varices and on the use of albumin in patients with cirrhosis among GI specialists in AustriaNikolaus Pfisterer, Caroline Schmidbauer, Florian Riedl, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 23, 2026
The Link of Portal-Hypertensive Gastropathy to Anaemia, Systemic Inflammation and Disease Progression in CirrhosisNikolaus Pfisterer, Irina Lie-Ungurean, Jurij Maurer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 25, 2018
Outcomes after placement of a SX-ELLA oesophageal stent for refractory variceal bleeding-A national multicentre studyNikolaus Pfisterer, Florian Riedl, Thomas Pachofszky, et al.
Molecular Metabolism|April 14, 2023
Carboxylesterase 2a deletion provokes hepatic steatosis and insulin resistance in mice involving impaired diacylglycerol and lysophosphatidylcholine catabolismGabriel Chalhoub, Alina Jamnik, Laura Pajed, et al.
JHEP Reports : Innovation in Hepatology|September 30, 2022
Alpha-1 antitrypsin Pi∗Z allele is an independent risk factor for liver transplantation and death in patients with advanced chronic liver diseaseLorenz Balcar, Bernhard Scheiner, Markus Urheu, et al.
Hepatology (Baltimore, Md.)|September 3, 2014
Growth hormone resistance exacerbates cholestasis-induced murine liver fibrosisPatricia Stiedl, Robert McMahon, Leander Blaas, et al.
International Journal of Cancer|December 23, 2014
Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinomaPatrick Reichl, Meng Fang, Patrick Starlinger, et al.
Alimentary Pharmacology & Therapeutics|April 5, 2023
Disturbances in sodium and chloride homeostasis predict outcome in stable and critically ill patients with cirrhosisGeorg Semmler, Bernhard Scheiner, Lorenz Balcar, et al.
Pageof 78